Cyclin D-1 protein over-expression is not associated with gene amplification in benign and atypical apocrine lesions of the breast

These results suggest that other post-transcriptional mechanisms might be responsible for cyclin D-1 protein over-expression in benign apocrine lesions. Further studies are needed to understand the mechanisms involved in abnormal cyclin D-1 expression in these lesions.